Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04901429 · ClinicalTrials.gov registry record · NA
Truncal Vagotomy in Patients Undergoing Revisional Sleeve Gastrectomy to Gastric Bypass
A NA study of GERD, sponsored by Baylor Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT04901429: Recruiting NA study of GERD, sponsored by Baylor Research Institute.
NCT04901429 is a NA study of GERD that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 200 participants, above the 154-participant average among 15 other GERD trials with a reported enrollment target (30% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04901429, a NA study of GERD, is actively recruiting participants, sponsored by Baylor Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the efficacy of performing a truncal vagotomy along with a sleeve to bypass revision surgery in reducing the severity and/or incidence of gastroesophageal reflux disease (GERD) post-surgery.
Primary Outcome
GERD-HRQL scores
Conditions Studied
Interventions
- PROCEDURE Truncal vagotomy
Study Locations (1)
Texas
- Baylor University Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2028-08-01 |
| Phase | NA |
What NCT04901429 shows while recruiting
NCT04901429 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 154-participant average among 15 other GERD trials with a reported enrollment target (30% higher).
The record links to 1 condition, with GERD appearing as the primary indexed condition, and to 1 intervention - of which Truncal vagotomy is the first listed.
NCT04901429 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04901429 about?
NCT04901429 is a clinical study titled "Truncal Vagotomy in Patients Undergoing Revisional Sleeve Gastrectomy to Gastric Bypass". The purpose of this study is to investigate the efficacy of performing a truncal vagotomy along with a sleeve to bypass revision surgery in reducing the severity and/or incidence of gastroesophageal reflux disease (GERD) post-surgery.
What is the current status of trial NCT04901429?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2021-07-01. Estimated completion is 2028-08-01.
What conditions does trial NCT04901429 study?
This clinical trial studies the following conditions: GERD.
What interventions are being tested in trial NCT04901429?
The interventions under investigation include: Truncal vagotomy (PROCEDURE).
Who is sponsoring clinical trial NCT04901429?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04901429 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for GERD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04901429's enrollment target sits among peer trials
200 4th of 15 higher than 12 of 15 other GERD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other GERD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mesh Vs Pledgets for Repair of Paraesophageal Hernia
RECRUITING · NA
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
The Effect of the Reflux Band™ Upper Esophageal Sphincter (UES) Assist Device on Reflux for Lung Transplant Recipients
RECRUITING · NA
-
Mechanisms Preventing Pharyngeal Reflux
RECRUITING · NA
-
Gracie Diet for Gastroesophageal Reflux Disease
ACTIVE NOT RECRUITING · NA
-
Multicenter Single-Blind RCT of CTIF Versus LNF For Treatment of GERD in Patients Requiring Hiatal Hernia Repair
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI